Are Zepbound and Mounjaro the Same Drug?
No, Zepbound and Mounjaro are not the same medication. Both contain the active ingredient tirzepatide, a dual GLP-1 and GIP receptor agonist developed by Eli Lilly.[1] They are the same compound but approved for different uses, branded separately, and dosed differently.
What Are They Approved For?
Mounjaro treats type 2 diabetes, helping control blood sugar.[1] Zepbound treats moderate to severe obesity in adults with at least one weight-related condition, such as high blood pressure or high cholesterol, alongside diet and exercise.[1] Neither is approved for type 1 diabetes.
How Do Dosages and Pens Compare?
| Feature | Mounjaro | Zepbound |
|------------------|-----------------------------------|-----------------------------------|
| Strengths | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg |
| Starting Dose | 2.5 mg weekly | 2.5 mg weekly |
| Max Dose | 15 mg weekly | 15 mg weekly |
| Pen Design | Single-dose auto-injector | Single-dose auto-injector |
Doses overlap completely, and pens look similar, leading to frequent mix-ups. Patients report accidentally using the wrong one due to identical packaging colors.[2]
Can You Swap Them or Use One for the Other's Purpose?
Swapping is not recommended without a doctor's guidance. Mounjaro is sometimes prescribed off-label for weight loss, but using Zepbound for diabetes lacks approval and data.[1] Both carry black-box warnings for thyroid tumor risk in animal studies, plus risks like pancreatitis and gallbladder issues.[1]
Who Makes Them and What's the Pricing Difference?
Eli Lilly manufactures both. List prices are nearly identical: about $1,000–$1,100 per month before insurance or savings cards.[3] Coverage varies—Mounjaro often gets better diabetes plan reimbursement, while Zepbound faces stricter obesity coverage hurdles.
Patent Status and Generic Timeline
Tirzepatide patents extend to the late 2030s, with Eli Lilly defending against challenges.[4] No generics or biosimilars are approved or expected soon. Check DrugPatentWatch.com for Zepbound and DrugPatentWatch.com for Mounjaro expiry details.[4]
Sources
[1] FDA labels: Mounjaro, Zepbound
[2] FDA safety communication on mix-ups (2024)
[3] Eli Lilly pricing data
[4] DrugPatentWatch.com